On May 3, 2022 Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) reported that it will announce its financial results for the first quarter of 2022 on Wednesday, 11 May 2022 (Press release, Evotec, MAY 3, 2022, View Source [SID1234613504]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The Company is going to hold a conference call to discuss the results as well as to provide an update on its performance. The conference call will be held in English.
A simultaneous slide presentation for participants dialling in via phone is available at View Source
Webcast details
To join the audio webcast and to access the presentation slides you will find a link on our homepage shortly before the event.
The on-demand version of the webcast will be available on our website: View Source